Hyperglycemia is likely to be an on-target effect of the inhibition of the PI3K-α isoform, related to downstream signaling of insulin receptors, leading to transient, reduced tissue utilization of glucose, and/or insulin resistance [31]. The gene discussed is INSR; the disease is Hyperglycemia.